Crisis Management during an Epidemic: General guidelines for efficient response coordination by national regulatory authorities, May 2020
MetadataShow full item record
Other Language Versions
Considering the advance of the COVID-19 (novel coronavirus SARS-CoV-2) pandemic and the resulting declarations of health emergencies in the countries of the Region of the Americas, it is necessary to clarify the role and responsibility of each country’s National Regulatory Authority (NRA) regarding medicines and to establish appropriate channels for its participation in a coordinated strategy at the country level to provide an agile response in the pandemic. To ensure timely access to essential medicines and health technologies during the pandemic, countries will almost certainly need to develop, update, or even relax their regulatory frameworks, processes, and procedures. These actions may be necessary, for example, to use registered products for off-label uses, ensure the quality of donated products, deal with shortages of health products, etc. The actions that the NRA will implement must be effective and time-saving, which means that the country should create a coordinating group or committee with clear functions. The objective of this document is to provide guidance to NRAs on how to establish/review/implement regulatory committees for crisis management, how to coordinate with other health authorities, and how to promote improvements in communication with other government entities, civil society, and other relevant actors, in the framework of the regulatory response to the COVID-19 pandemic.
This notice should be preserved along with the article's original URL.Attribution-NonCommercial-ShareAlike 3.0 IGO
Showing items related by title, author, creator and subject.
Reliance for Emergency Use Authorization of Medicines and Other Health Technologies in a Pandemic (e.g. COVID-19) Pan American Health Organization; Health Systems and Services (HSS) (PAHOUnited StatesWashington, D.C., 2020)Purpose and Context: This document provides guidance to national regulatory authorities (NRAs) and regulatory systems on practical ways to implement reliance for emergency use of medicines and other health technologies in ...
Regulatory System Strengthening in the Americas. Lessons Learned from the National Regulatory Authorities of Regional Reference Pan American Health Organization; Health Systems and Services (HSS) (PAHOUnited StatesWashington, D.C., 2021)Improving access to safe, effective, and quality medicines and other health technologies is a critical public health priority and a fundamental requisite for universal health. National regulatory systems play a key part ...
Pan American Health Organization; Health Emergencies (PHE) (PAHOUnited StatesWashington, D.C., 2020-08-24)Regional. PAHO continued to collaborate with its partners within the Region and across the globe to deliver technical cooperation, evidence-based guidance, and recommendations, and to advocate for the Americas on the global ...